This study uses the Tg(SOD1*G93A)1Gur/J transgenic mouse model to understand the pathogenesis of ALS and explores the regulatory mechanisms of APG on ALDH1A2, thus laying the foundation for potential clinical applications of APG for ALS patients. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.